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Abstract 
Purpose: To assess the ability of quantitative pupillometry [using the Neurological Pupil index (NPi)] to predict an 
unfavorable neurological outcome after cardiac arrest (CA).
Methods: We performed a prospective international multicenter study (10 centers) in adult comatose CA patients. 
Quantitative NPi and standard manual pupillary light reflex (sPLR)—blinded to clinicians and outcome assessors—
were recorded in parallel from day 1 to 3 after CA. Primary study endpoint was to compare the value of NPi versus 
sPLR to predict 3‑month Cerebral Performance Category (CPC), dichotomized as favorable (CPC 1–2: full recovery or 
moderate disability) versus unfavorable outcome (CPC 3–5: severe disability, vegetative state, or death).
Results: At any time between day 1 and 3, an NPi ≤ 2 (n = 456 patients) had a 51% (95% CI 49–53) negative predic‑
tive value and a 100% positive predictive value [PPV; 0% (0–2) false‑positive rate], with a 100% (98–100) specificity and 
32% (27–38) sensitivity for the prediction of unfavorable outcome. Compared with NPi, sPLR had significantly lower 
PPV and significantly lower specificity (p  < 0.001 at day 1 and 2; p  = 0.06 at day 3). The combination of NPi ≤ 2 with 
bilaterally absent somatosensory evoked potentials (SSEP; n = 188 patients) provided higher sensitivity [58% (49–67) 
vs. 48% (39–57) for SSEP alone], with comparable specificity [100% (94–100)].
Conclusions: Quantitative NPi had excellent ability to predict an unfavorable outcome from day 1 after CA, with no 
false positives, and significantly higher specificity than standard manual pupillary examination. The addition of NPi to 
SSEP increased sensitivity of outcome prediction, while maintaining 100% specificity.
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Introduction
Approximately one-half of patients admitted to the inten-
sive care unit (ICU) in coma following a cardiac arrest 
(CA) die or have an unfavorable neurological outcome at 
hospital discharge [1, 2]. Mortality in comatose resusci-
tated CA patients predominantly results from the with-
drawal of life-sustaining therapies (WLST), based upon 
the prediction of severe irreversible post-anoxic brain 
damage [3, 4]. Clinical neurological examination, and in 
particular the pupillary light reflex (PLR), is a key com-
ponent of the prognostic assessment of CA patients [5, 
6]. In subjects who remain comatose on day 3 after CA, 
a bilaterally absent PLR is considered as highly spe-
cific for poor neurological outcome [7–9], and is cur-
rently recommended—in combination with the bilateral 
absence of N20 wave on short-latency somatosensory 
evoked potentials (SSEP)—as the most accurate test for 
prognosticating outcome of coma after CA [6]. However, 
it must be recognized that the quality of evidence sup-
porting prognostic tests based on clinical examination is 
limited by both the absence of an objective quantitative 
assessment of pupillary function and the lack of blinded 
measurements, i.e. the results of the index test are usually 
available to clinicians involved in patient care and WLST 
decisions, thereby causing a self-fulfilling prophecy [10].
Automated infrared pupillometry provides a quantita-
tive measurement of pupillary response to a calibrated 
light stimulus [11, 12] and improves reliability and 
validity in comparison with the standard manual meth-
ods for the subjective assessment of PLR, especially in 
the acute neurological setting [13–15]. Recent studies 
have suggested that quantitative PLR (qPLR; expressed 
as the percentage pupillary constriction to a calibrated 
light stimulus) may improve prediction of neurological 
outcome after CA [16–19]. Most of these studies, how-
ever, were single-centered and had both a small sample 
size and/or an absent or incomplete blinding, and only 
qPLR was examined. Quantitative pupillometry, however, 
allows a more comprehensive assessment of pupillary 
function, in particular when using the Neurological Pupil 
index (NPi). The NPi is a scalar value (between 0 and 5) 
which is calculated based on an algorithm that accounts 
for several measured pupillary variables, including size, 
percentage constriction, constriction velocity, dilation 
velocity, and latency [20]. Contrary to the qPLR, the NPi 
is only minimally influenced by medications (in particu-
lar, opioids) and ambient light, and it accounts for indi-
vidual baseline pupil size [20–23].
We therefore designed a multicenter study in comatose 
post-CA patients to assess the prognostic accuracy of 
quantitative pupillometry, performed in a blinded fash-
ion and on an adequately sized population. The primary 
study endpoint was to examine the value of NPi in com-
parison to that of standard manual PLR (sPLR). Addi-
tionally, we analyzed the value of the NPi when used in 
combination with SSEP.
Patients and methods
Study design
This was an investigator-initiated, prospective, multi-
center, international prognostication study conducted 
in ten European ICUs (ClinicalTrials.gov Identifier: 
NCT02607878). Centers were selected within the Neuro-
intensive Care section of the European Society of Inten-
sive Care Medicine (ESICM), based on their expertise 
on prognostication after CA. The study protocol was 
approved by the Ethical Committee at each institution, 
and written informed consent to participate in the study 
was obtained from patients’ next of kin or a legal surro-
gate, according to local ethical recommendations. Accu-
racy of the collected data was monitored by principal and 
local investigators. Study design and methodology was 
in accordance with the STARD guidelines for reporting 
diagnostic accuracy studies [24].
Role of the funding source
The device manufacturer  (Neuroptics®, Irvine, CA, USA) 
supplied equipment and disposables for the study, but it 
did not provide any financial support for the study and 
had no role in the study design, data collection, analysis 
and interpretation, or writing of the report.
Blinding
The ICU clinicians/nurses who performed pupillometry 
tests were not involved in patient care and the outcome 
assessors were blinded to quantitative pupillometry data. 
Decisions about intensity of care and WLST were based 
on a local prognostication algorithm at each center (see 
below) which did not include any of the pupillometry 
data.
Take‑home message 
A novel tool for the automated measurement of the pupillary func‑
tion, assessed blindly in a large multicentre international prospec‑
tive study, already had 100% specificity and positive predictive value 
to predict unfavourable outcome in comatose post‑anoxic patients 
by day 1 after cardiac arrest.
The Quantitative Neurological Pupil index, unaffected by confound‑
ers such as hypothermia and sedation, had significantly higher 
specificity than standard pupillary light reflex, with no false positives.
These findings have potentially important clinical implications and 
indeed demonstrate that early prognostication, using quantitative 
devices for the objective assessment of pupillary function, appears 
accurate and reliable across different cardiac arrest centers.
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Participants
Patients were adult subjects (> 18  years) with coma 
(Glasgow Coma Score ≤ 6) following a CA (regard-
less of the initial arrest rhythm), admitted to the ICU 
from January 2015 to March 2017. Patients were 
treated according to the European Resuscitation Coun-
cil (ERC)–ESICM guidelines for post-resuscitation 
care [5], including TTM (33 or 36  °C, according to 
local practices at each center) and sedation (mida-
zolam or propofol)/analgesia (morphine, fentanyl or 
remifentanyl).
Demographic and clinical variables
Demographic and clinical variables included age, gen-
der, initial arrest rhythm [categorized as shockable 
(ventricular fibrillation) vs. non-shockable (asystole or 
pulseless electrical activity)], duration of CA [defined 
as the time from CA to return of spontaneous circu-
lation (ROSC)], admission norepinephrine dose, and 
admission body temperature, TTM target temperature 
(categorized as TTM 33 °C or TTM 36 °C), TTM dura-
tion, and the total cumulative dose over the first 48 h of 
sedatives, analgesics, and norepinephrine.
Intervention
Quantitative pupillometry (index test) was performed 
using the  NPi®-200 pupillometer  (Neuroptics®). The 
 NPi®-200 uses an infrared camera that integrates a cali-
brated light stimulation of fixed intensity (1000 Lux) 
and duration (3.2 s), allowing a rapid and precise meas-
ure (0.05 mm limit) of the pupil size and of a series of 
several dynamic pupillary variables. Based on an inte-
grated algorithm, the  NPi®-200 calculates the NPi. 
Pupil variables (including size, percentage constriction, 
latency, constriction velocity, and dilation velocity) are 
all parameters of the NPi algorithm [20]. Each variable 
from an individual pupil measurement, taken by the 
pupillometer, is compared against the mean of a refer-
ence distribution of healthy subjects for the same vari-
able. Finally, the set of all the standardized differences 
are combined to fall into a scale set between 0 and 5 
(with 0.1 decimal precision). An NPi score ≥ 3 defines 
normal pupillary light reactivity; for example, a value 
of 4.7 is considered more reactive than a value of 3.2. 
An NPi score < 3 denotes an abnormal pupillary light 
reactivity (i.e., weaker than a normal pupil response, as 
defined by the multidimensional normative model); for 
example, a value of 1.5 is more abnormal than a value 
of 2.8.
Quantitative pupillometry tests were performed on 
each eye daily from day 1 to 3 after CA and included 
the NPi and the qPLR (expressed as the percentage of 
pupillary constriction to the standardized light stimu-
lus). At each time-point, the lowest value (for both NPi 
and qPLR) from each eye was retained for the analysis.
Standard pupillary light reflex (sPLR) (reference stand-
ard) was performed by the nurse or the clinician in charge 
of the patient in parallel, at the same time-points, using a 
manual flash lamp. Absent sPLR was defined when pupil-
lary reactivity was not present bilaterally. There was no 
pre-specified sequential order for NPi or sPLR.
Prognostication and WLST
Outcome prediction was based on local prognostication 
algorithms that included the sPLR and at least one addi-
tional modality among SSEP, electroencephalography 
(EEG), and serum neuron specific enolase (NSE). Prog-
nostication tests were performed at days 1–3, irrespec-
tive of sedation/analgesia. Decisions about continuation 
of care or WLST were taken based on current prog-
nostication algorithms [5, 6, 25]; however, the choice of 
the combination of the additional prognosticating tests 
(SSEP, EEG, NSE) was left to the discretion of each inves-
tigator, based on routine practices at each center.
Outcome
Outcome was assessed at 3 months, using the Glasgow–
Pittsburgh Cerebral Performance Categories (CPC), 
dichotomized as favorable (CPC 1 = full recovery and 
2 = moderate disability, returned home) versus unfavora-
ble (including CPC 3 = severe disability, at rehabilitation 
facility, 4 = vegetative state and 5 = death) [26, 27].
Study endpoints
The primary endpoint of this study was to examine the 
performance of quantitative NPi in predicting 3-month 
unfavorable outcome and to compare its prognostic value 
to that of sPLR. ERC-ESICM guidelines on post-resusci-
tation care recommend using pupillary reflexes and SSEP 
as the initial step for the prognostication of post-cardiac 
arrest patients [5, 6]; therefore, as additional endpoint, 
we evaluated the prognostic value of the NPi when used 
in combination with SSEP.
Statistical analysis
Descriptive statistics were computed for all study 
variables and normal distribution was assessed using 
the Kolmogorov–Smirnov test. Differences between 
groups were compared using the Wilcoxon test for 
continuous variables and the Fisher exact test for cat-
egorical variables. Data are presented as counts (per-
centage) or median (interquartile range). Prognostic 
performance of each predictor was analyzed by calcu-
lating specificity, sensitivity, positive predictive value 
(PPV), negative predictive value (NPV), false-positive 
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rate (FPR) and the area under the receiver operating 
characteristic (ROC) curve. For the combination of 
NPi with SSEP, in patients where both tests were per-
formed, if the N20 SSEP wave was bilaterally absent 
and NPI was between 0 and 2, they were identified as 
having a positive test. Instead, the absence of one or 
both these characteristics was identified as a negative 
test. Sensitivity and specificity for prediction of a poor 
outcome were calculated accordingly.
Statistical differences between AUCs were computed 
using the method described by De Long et al. [28]. The 
Mc Nemar test was used to compare specificity and 
sensitivity for unfavorable outcome of NPi versus sPLR 
at each time point. For continuous predictor variables, 
the optimal cut-offs, i.e. those maximizing the Youden 
index and the specificity, were also identified. Accord-
ing to Jones et  al. [29], based on a specificity of 95% 
for qPLR in previous studies [16–18], a 95% confidence 
interval of 3%, and a prevalence of poor neurological 
outcome of 50%, a sample size of at least 400 patients 
was calculated. Statistical analysis was performed 
using STATA 12 (STATA ®, College Station, TX, USA). 
Significance was set at p < 0.05.
Results
Patient characteristics
The study flow-chart is summarized in Fig.  1. From a 
total of 477 patients included, 456 patients were suc-
cessfully analyzed for the primary endpoint. All patients 
underwent TTM for 24 h [199 (44%) in whom TTM was 
set at 33  °C, and 257 (56%) who had TTM at 36  °C]. At 
3  months, 187 patients (41%) had a favorable outcome, 
including CPC 1 (n = 133) and CPC 2 (n = 54). A total of 
269 patients (59%) had an unfavorable outcome, includ-
ing CPC 3 (n = 19), CPC 4 (n = 7) and CPC 5 (n = 243).
The general patient characteristics, according to the 
two outcome subgroups, are reported in Table 1. Patients 
with an unfavorable outcome were significantly older 
and had significantly higher rates of non-shockable 
CA rhythms and longer CA duration than those with a 
favorable outcome. The proportion of TTM at 33 versus 
36 °C, TTM duration, admission norepinephrine, and the 
48-h cumulative doses of sedatives, analgesics and nor-
epinephrine did not differ significantly between the two 
outcome groups.
Prognostic value of Neurological Pupil index (NPi) 
and quantitative pupillary light reflex (qPLR)
At each time point, median NPi and qPLR values 
were significantly higher in the favorable versus the 
Fig. 1 Study flow chart. CPC Cerebral Performance Category
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unfavorable outcome group (ESM_Table  1). Distribu-
tions across the two main outcome groups of individual 
NPi values at day 1 to 3 after CA are illustrated in Fig. 2. 
ESM_Figure  1 illustrates the distributions of qPLR at 
each time-point for both outcome groups. ESM_Table 2 
summarizes the cut-off values associated to a specificity 
ranging from 95% to 100%, i.e. a false positive rate from 
5% to 0%, along with those maximizing the Youden index 
Table 1 Patient characteristics
Data are presented as count (percentage) or median (interquartile range)
ROSC return of spontaneous circulation, TTM targeted temperature management
Variable Favorable outcome (n = 187) Unfavorable outcome (n = 269) p value
Age, years 60 (49–69) 65 (54–74) 0.0006
Male gender, n (%) 154 (80) 203 (72) 0.03
Non‑shockable rhythm, n (%) 36 (19) 160 (57) < 0.0001
Time from cardiac arrest to ROSC, min 19 (10–29) 28 (16–41) < 0.0001
Admission norepinephrine dose, µg/min 5.7 (2.4–10.5) 5.9 (1.4–19) 0.71
Admission body temperature,  °C 35.5 (34.6–36.1) 35 (34–35.8) 0.001
TTM at 33 °C, n (%) 85 (42%) 116 (58%) 0.73
TTM at 36 °C, n (%) 103 (40%) 152 (60%)
TTM duration, hours 24 (24–24) 24 (24–24) 0.85
48‑h propofol dose, mg/h 1.7 (1.1–2.4) 1.8 (1.3–3.7) 0.48
48‑h midazolam dose, mg/kg/h 0.08 (0.04–0.15) 0.11 (0.06–0.37) 0.19
48‑h fentanyl dose, µg/kg/h 0.49 (0.26–1.4) 0.55 (0.14–1.4) 0.94
48‑h norepinephrine dose, µg/min 4.9 (1–15) 5.4 (1–15) 0.91
Fig. 2 Distributions of Neurological Pupil index (NPi) during the first 3 days after cardiac arrest according to patient 3‑month outcome. Scatterplots 
showing individual NPi values on days 1, 2 and 3 according to 3‑month Cerebral Performance Category (CPC) outcome group, dichotomized as 
favorable (CPC 1–2; open circles) and unfavorable (CPC 3–5; filled squares)
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for both predictors; no qPLR values corresponding to 
100% specificity at days 1 and 2 were found. At all time-
points, the ability to predict outcome, assessed using the 
AUC (95% confidence interval), was higher for NPi than 
for qPLR: 0.77 (0.73–0.81) versus 0.76 (0.72–0.80) on day 
1 (p  = 0.73); 0.76 (0.72–0.81) versus 0.73 (0.68–0.78) on 
day 2 (p  = 0.81); 0.78 (0.72–0.83) versus 0.71 (0.65–0.77) 
on day 3 (p  = 0.04); Fig. 3.
A cut-off for NPi ≤ 2, occurring at any time between 
day 1 and day 3, provided maximum s ensitivity   [32% 
(27–38)] to predict unfavorable outcome, while achiev-
ing 100% (98–100) specificity and 100% positive predic-
tive value [0% (0–2) false-positive rate] (Table  2). Using 
the cut-off of abnormal NPi (< 3) [23] increased sensitiv-
ity [38% (32–44)] but at the expense of a lower specificity 
[96% (92–98); 6% FPR].
Prognostic value of standard manual pupillary light reflex 
(sPLR)
The specificity of bilaterally absent sPLR for unfavora-
ble outcome was 90% on day 1 and 2, increasing to 94% 
(86–98) on day 3; sensitivity decreased from 35% (29–42) 
to 18% [11–26], respectively (Table 2). Five of 78 patients 
who had bilaterally absent sPLR on day 3 eventually had a 
favorable outcome (6% FPR). Of note, all five patients had 
smaller pupil size (1.9 ± 0.22 vs. 2.8 ± 1.05  mm in those 
Fig. 3 Performance of Neurological Pupil index (NPi) versus quantitative pupillary light reflex (qPLR) to predict 3‑month outcome (Cerebral Perfor‑
mance Category) at day 1 to 3 after cardiac arrest. Diagrams illustrate the area under the ROC curve (AUC) of qPLR (blue line) and NPi (grey line at 
days 1, 2 and 3; p for comparison of NPi AUC versus qPLR AUC. AUC of NPI to predict outcome at day 3 after cardiac arrest was significantly better 
than the AUC of qPLR [AUC 0.78 (0.72–0.83) vs. 0.71 (0.65–0.77) on day 3 (p  = 0.04)]
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with unfavorable outcome, p   = 0.009) and lower qPLR 
(15 ± 2 vs. 24 ± 8%, p  = 0.01), but their NPi was normal 
(4.5 ± 0.1 vs. 4.4 ± 0.4, p  = 0.72).
Compared to NPi ≤ 2, sPLR had a lower performance 
to predict an unfavorable outcome at each time point 
tested, both in terms of specificity (p   < 0.0001 at day 
1; p   < 0.001 at day 2; p   = 0.06 at day 3) and sensitivity 
(p  < 0.0001 at day 1; p  = 0.0003 at day 2; p  = 0.18 at day 
3; McNemar test).
Additional data: combination of quantitative NPi and SSEP 
to predict unfavorable outcome
In a subset of 188 patients for whom SSEP were avail-
able, we found that a bilaterally absent N20 wave had 
48% (39–57) sensitivity and 100% (94–100) specificity 
for unfavorable neurological outcome at 3  months. The 
combination of bilaterally absent SSEP with an NPi ≤ 2 
provided the highest sensitivity of all tests (58% (49–66), 
with comparable specificity 100% (94–100) (Table  2). 
Furthermore, among the 56/123 patients with normal 
SSEP and unfavorable outcome (i.e. false negatives), 15 
(27%) had NPi ≤ 2 and were therefore correctly predicted 
only by quantitative pupillometry.
Discussion
This is the largest multicenter study on the prognostic 
value of pupillary reactivity in the acute phase of post-
anoxic coma. Its main findings are that, in patients who 
are comatose following resuscitation from cardiac arrest, 
a quantitative measurement of the pupillary function, 
using automated infrared pupillometry, predicted an 
unfavorable neurological outcome at 3  months more 
accurately than standard pupillary examination using 
a manual device. The predictive value for an unfavora-
ble outcome of NPi was superior to that of sPLR at each 
time-point tested (Table 2). Further analysis to compare 
prognostic performance between the two tests at sepa-
rate time points provided significantly higher specific-
ity and sensitivity to predict an unfavorable outcome for 
NPi versus sPLR; these differences were statistically sig-
nificant at days 1 and 2 (both for specificity and sensitiv-
ity), while an almost significant trend in favor was found 
at day 3 for specificity of NPi versus sPLR. In particular, 
NPi ≤ 2  already had 100% specificity and positive pre-
dictive value  at a very early time-point (day 1) following 
cardiac arrest. This is in contrast with the common find-
ing that pupillary reactivity achieves its maximal specific-
ity not earlier than day 3 [8, 9, 30]. A likely explanation 
of this finding is that—differently from the sPLR—NPi 
is a continuous scaled variable that allows discrimina-
tion between various degrees of severity of post-anoxic 
pupillary dysfunction. Our study further indicates that an 
accurate prediction of poor neurological outcome using 
PLR does not require a complete abolition of pupillary 
reactivity; in our cohort, in fact, a significant reduction 
of NPi (≤ 2) was a sufficient criterion. Regarding NPi, 
previous reports described NPi < 3 as the threshold for 
abnormality [23]: in our study, however, this cut-off did 
not achieve 100% specificity for a 3-month unfavorable 
outcome after CA.
Preliminary single-center studies, evaluating the value 
of quantitative pupillometry, focused exclusively on the 
Table 2 Specificity, sensitivity, positive predictive value, negative predictive value and false‑positive rate for unfavora‑
ble outcome (CPC 3–5) of the different prognostic tests
CI confidence interval, CPC Cerebral Performance Category
Day after car-
diac arrest
Sample size
(n)
CPC 3–5
n (%)
Specificity
% (95% CI)
Sensitivity
% (95% CI)
Positive predictive value
% (95% CI)
Negative pre-
dictive value
% (95% CI)
False-positive rate
% (95% CI)
Neurological pupil index (NPi) ≤ 2
 Day 1–3 456 269 (59) 100 (98–100) 32 (27–38) 100 (100–100) 51 (49–53) 0 (0–2) %
 Day 1 450 264 (59) 100 (98–100) 22 (17–27) 100 (100–100) 47 (46–49) 0 (0–2) %
 Day 2 361 213 (59) 100 (98–100) 19 (14–25) 100 (100–100) 46 (45–48) 0 (0–2) %
 Day 3 271 166 (61) 100 (97–100) 17 (12–24) 100 (100–100) 43 (41–44) 0 (0–3) %
Bilaterally absent standard pupillary light reflex (sPLR)
 Day 1 392 225 (57) 90 (85–94) 35 (29–42) 83 (75–89) 51 (48–54) 10 (6–15)  %
 Day 2 278 163 (59) 90 (84–95) 29 (22–36) 81 (70–89) 47 (44–50) 10 (5–16)  %
 Day 3 206 128 (62) 94 (86–98) 18 (12–26) 82 (65–92) 41 (39–43) 6 (2–14)  %
Bilaterally absent somatosensory evoked potentials (N20 wave)
 Day 2–3 188 133 (71) 100 (94–100) 48 (39–57) 100 (100–100) 44 (40–48) 0 (0–6) %
Combination of NPi ≤ 2 and bilaterally absent somatosensory evoked potentials
 Day 2–3 188 133 (71) 100 (94–100) 58 (49–66) 100 (100–100) 55 (50–59) 0 (0–6) %
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qPLR and found variable cut-offs of 100% specificity for 
poor prognosis, with thresholds varying from 10% [16] 
to 13% [17, 18]. These studies used other devices that did 
not compute automated NPi. Our study suggests that 
NPi may have better prognostic performance than qPLR, 
at least at day 3. In fact, we did not test different devices, 
and, therefore, we cannot speculate about potentially dif-
ferent prognostic performances between pupillometry 
devices. However, the advantage of using NPi in the set-
ting of CA where sedation and analgesia may diminish 
pupil size, is that, contrary to qPLR, NPi is not affected 
by opioids and small pupil size [23].
Differently from previous prognostication studies, we 
could not confirm 100% specificity for a bilaterally absent 
sPLR on day 3. In fact, sPLR was scored as absent on day 
3 in 5/79 patients who eventually had a favorable out-
come (FPR 6%). Although unexpected, this finding is not 
completely unprecedented; previous studies by Bouwes 
et al. [31] and Dragancea et al. [32] found a FPR > 0% for 
bilaterally absent sPLR (FPR 1% and 2.1%, respectively). It 
should be noted that, similar to our study, both  theabove 
studies had a large sample size, were multicentered, and 
involved non-neurologists for the assessment of the 
standard PLR. One possible explanation of our findings 
may be that in a few patients standard PLR recording 
may have been suboptimal. If this was the case, our study 
indeed supports the notion that standardized objective 
pupillary assessment using automated pupillometry—
rather than manual subjective assessment—may limit the 
risk of an incorrect PLR test [13–15], and, consequently, 
reduce falsely pessimistic prognostic prediction. Another 
plausible explanation for the observed five false positive 
manual PLR results was that in all these patients pupils 
were miotic and qPLR was on average 15%, correspond-
ing to a variation in pupil size of only about 0.25  mm, 
which most likely was too small to be detected by manual 
assessment. This again reinforces the utility of quantita-
tive pupillometry and further underlines the potential 
advantage of NPi, which is unaffected by pupil size [23], 
since NPi was completely normal in all of these patients.
In line with current ERC–ESICM guidelines on prog-
nostication after CA [5, 6], the results of our study con-
firm that the assessment of PLR allows the prediction of 
an unfavorable outcome with high accuracy and preci-
sion and further support the use of quantitative NPi to 
minimize the risk of a false positive prediction. In addi-
tion, our study suggests that the outcome may be pre-
dicted earlier than what is currently recommended using 
sPLR. As for other quantitative prognosticators, such as 
serum NSE [33], NPi results could, therefore, be simi-
larly collected during the first 3 days after CA and con-
sidered at the recommended time point of ≥ 72  h from 
CA [6]. Finally, we confirmed that the recommended 
combination of PLR and SSEP increases the sensitivity to 
predict an unfavorable outcome 3 days after CA, but the 
novelty of our findings was that 100% specificity could be 
reached only when quantitative NPi was used.
Study limitations
First, this study was observational and, as such, no homo-
geneous WLST protocol was imposed to the treating 
teams of the participating centers. However, all centers 
consistently applied their local WLST protocol, which 
was based on ERC–ESICM prognostication guidelines [6, 
34] or equivalent algorithms [25, 35]. These recommen-
dations should be the benchmark of every current prog-
nostication study. Second, although clinicians involved 
in patient care were blinded to the results of quantitative 
pupillometry, this did not occur for sPLR, which was part 
of prognostication protocol. WLST decisions, however, 
were never based on a single predictor. NPi and sPLR are 
not equivalent, as demonstrated by their different specifi-
cities; however, as both tests are based on pupillary light 
reactivity, although to a lesser extent than for sPLR, some 
degree of self-fulfilling bias also cannot be completely 
excluded for NPi. Third, prognostic tests (especially at 
days    1 and 2) were performed in patients who were 
under sedation and analgesia, which may have reduced 
the accuracy of manual PLR assessments; as discussed 
above, miosis was associated with false positive predic-
tions for s-PLR. In this setting, since it is not altered by 
sedatives/analgesics, NPi may confer a significant advan-
tage over sPLR and provide accurate prognostic infor-
mation, particularly in those patients with sedation or 
delayed awakening, which may represent up to 30% of 
cases [35]. Fourth, there was no sequential order for NPi 
and sPLR, and we cannot entirely rule out that in some 
cases the sPLR could have been recorded from an opera-
tor who was aware of the automated pupillometry results.
Conclusions
Our main findings are that a NPi ≤ 2, performed at 
any time between day 1 and day 3 following hospital 
admission, was 100% specific to predict an unfavorable 
3-month neurological outcome and provided greater 
prognostic performance than standard manual pupil-
lary light reactivity. Our data further suggest that using 
a prognostic approach that combines the NPi with soma-
tosensory evoked potentials improved the sensitivity to 
predict an unfavorable outcome in patients with cardiac 
arrest, while providing equal 100% specificity. Future 
studies are needed to examine the value of a multimodal, 
prognostic algorithm that integrates a quantitative NPi
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